Moderna answers GSK move to dismiss counterclaims in vaccine patent suits – MLex
Moderna answers GSK move to dismiss counterclaims in vaccine patent suits MLex
In: PATENT NEWS
Moderna answers GSK move to dismiss counterclaims in vaccine patent suits MLex
In: PATENT NEWS
Criminal Law · Employment and HR · Energy and Natural … Düsseldorf UPC Ruling And Turkey: How Far Unified Patent Court Can Extend Its Reach?
In: PATENT NEWS
The new category includes multiple legal specialties, from corporate law to human rights advocacy, intellectual property law, and regulatory …
In: PATENT NEWS
… patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply …
In: COPYRIGHT NEWS
News/Media Alliance Announces New Industry Lawsuit Against AI Content Theft News/Media Alliance
In: PATENT NEWS
… intellectual property rights in China. The complexities of Chinese law … Lacking formal IP protection in China, the apparel company’s options were …
In: PATENT NEWS
New data, old debates: US government-funded R&D and patent policy CEPR
In: PATENT NEWS
McGill law professor Richard Gold suggests Canada should suspend patents in sectors such as pharma and AI.
In: PATENT NEWS
Fighting Back: Could Tough Patent Policy Help Canada Put Pressure on U.S. in Battle Over Tariffs? Law.com International
In: PATENT NEWS
Nuix earns patent for AI breakthrough in document sorting ChannelLife Australia
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION